LeMaitre Vascular, Inc. (LMAT)
111.65
-3.16
(-2.75%)
USD |
NASDAQ |
Apr 16, 16:00
110.50
-1.15
(-1.03%)
Pre-Market: 20:00
LeMaitre Vascular Research and Development Expense (Quarterly) : 3.533M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Apyx Medical Corp. | 0.944M |
| Integer Holdings Corp. | 10.11M |
| Intuitive Surgical, Inc. | 352.90M |
| Globus Medical, Inc. | 36.16M |
| PROCEPT BioRobotics Corp. | 19.06M |